跳到正文
原文
Nature 健康护理主题·· 25 天前AI 评分34

First-day Braden score 更准确预测 ICU 患者压力损伤风险

First-day Braden score carries more prognostic information than vasoactive dose for pressure injury in ICU patients receiving early vasoactive support

AI 导读

在 17,148 名 ICU 患者中,入院 24 小时内的 Braden 评分比最高血管活性药物剂量更能准确预测压力损伤风险。研究发现,Braden 评分与死亡和出院的竞争风险模型中关联最强,且优于最高剂量,尽管差异较小。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Vasopressor exposure is a reported risk factor for intensive care unit (ICU)-acquired pressure injury, but its prognostic information relative to bedside risk assessment is unknown. In this retrospective single-centre MIMIC-IV cohort of 17,148 adult ICU stays that started vasoactive support within 24 h and remained in the ICU, alive and free of documented injury, at 24 h, 1,833 (10.7%) had a newly documented pressure injury. Peak norepinephrine-equivalent dose, duration of support, hypotension burden and the Braden Scale, measured in the first 24 h, were entered simultaneously in a cause-specific Cox model with death and discharge as competing events. The first-day Braden score had the largest standardized association (hazard ratio 0.77, 95% CI 0.73–0.81 per standard deviation), ahead of hypotension burden (1.10) and peak dose (1.07), and improved discrimination more than peak dose, although modestly. In exploratory analyses, associations were concentrated in the first week, and for lesions severe at first documentation, mostly deep tissue injuries, peak dose was no longer clearly associated after full adjustment including first-day illness severity, whereas duration of support was. In a 48 h landmark subset, whole-stay summarization inflated the Braden association by 58%. First-day bedside assessment carried more prognostic information than vasoactive dose.

Acknowledgements

The authors thank the investigators and institutions responsible for developing and maintaining the MIMIC-IV database and for making it available to the research community.

Funding

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Author notes

  1. Yaling Huang and Lujun Shao contributed equally to this work.

Authors and Affiliations

  1. Department of Nursing, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, China

    Yaling Huang

  2. Department of Intensive Care Unit, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, China

    Lujun Shao, Yue Li & Ke Cai

  3. Graduate School of Medicine, Hirosaki University, Hirosaki, Aomori, Japan

    Lujun Shao

Authors

  1. Yaling Huang
  2. Lujun Shao
  3. Yue Li
  4. Ke Cai

Corresponding author

Correspondence to Ke Cai.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, Y., Shao, L., Li, Y. et al. First-day Braden score carries more prognostic information than vasoactive dose for pressure injury in ICU patients receiving early vasoactive support. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76233-1

Download citation

  • Received: 22 August 2026

  • Accepted: 12 October 2026

  • Published: 26 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-76233-1

Keywords

来源:Nature 健康护理主题 · nature.com